⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IMUX News
Immunic, Inc. Common Stock
Q3 2025 Contract Research Organization (CRO) Activity and Intel Report Featuring ICON, Astrazeneca, Akesobio, CSPPC Pharmaceutical, ImmunityBio, and Boryung
globenewswire.com
ICLR
AZN
IMUX
Immunic to Participate in Industry and Investor Conferences in November
prnewswire.com
IMUX
IMUX
Immunic to Participate in Scientific and Investor Conferences in October
prnewswire.com
IMUX
IMUX
Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis
prnewswire.com
IMUX
IMUX
Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis
prnewswire.com
IMUX
IMUX